MCPIP1 Endoribonuclease Activity Negatively Regulates Interleukin-17-Mediated Signaling and Inflammation.

[1]  Sanjay Kumar,et al.  Transcription Factors STAT6 and KLF4 Implement Macrophage Polarization via the Dual Catalytic Powers of MCPIP , 2015, The Journal of Immunology.

[2]  Osamu Takeuchi,et al.  Regnase-1 and Roquin Regulate a Common Element in Inflammatory mRNAs by Spatiotemporally Distinct Mechanisms , 2015, Cell.

[3]  A. Leonardi,et al.  CIKS/DDX3X Interaction Controls the Stability of the Zc3h12a mRNA Induced by IL-17 , 2015, The Journal of Immunology.

[4]  M. Kriegsmann,et al.  Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation. , 2014, Cell reports.

[5]  Yu-Chih Liang,et al.  MCPIP1 Suppresses Hepatitis C Virus Replication and Negatively Regulates Virus-Induced Proinflammatory Cytokine Responses , 2014, The Journal of Immunology.

[6]  E. Kremmer,et al.  Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote TH17 differentiation , 2014, Nature Immunology.

[7]  Zhiyun Wang,et al.  Toll-like receptor signaling directly increases functional IL-17RA expression in neuroglial cells. , 2014, Clinical immunology.

[8]  Yan Li,et al.  Interleukin-17 (IL-17)-induced MicroRNA 873 (miR-873) Contributes to the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting A20 Ubiquitin-editing Enzyme* , 2014, The Journal of Biological Chemistry.

[9]  Sarah L. Gaffen,et al.  The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing , 2014, Nature Reviews Immunology.

[10]  M. Moore,et al.  Post-transcriptional regulation of gene expression in innate immunity , 2014, Nature Reviews Immunology.

[11]  M. Fu,et al.  USP10 inhibits genotoxic NF‐κB activation by MCPIP1‐facilitated deubiquitination of NEMO , 2013, The EMBO journal.

[12]  S. Holland,et al.  The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseases , 2013, Nature Reviews Immunology.

[13]  S. Erzurum,et al.  HuR Is Required for IL-17–Induced Act1-Mediated CXCL1 and CXCL5 mRNA Stabilization , 2013, The Journal of Immunology.

[14]  S. Gaffen,et al.  The Deubiquitinase A20 Mediates Feedback Inhibition of Interleukin-17 Receptor Signaling , 2013, Science Signaling.

[15]  S. Akira,et al.  mRNA degradation by the endoribonuclease Regnase-1/ZC3H12a/MCPIP-1. , 2013, Biochimica et biophysica acta.

[16]  S. Akira,et al.  Malt1-Induced Cleavage of Regnase-1 in CD4+ Helper T Cells Regulates Immune Activation , 2013, Cell.

[17]  H. Kiyonari,et al.  Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo , 2013, Proceedings of the National Academy of Sciences.

[18]  R. Winzen,et al.  Interleukin-17 (IL-17) and IL-1 Activate Translation of Overlapping Sets of mRNAs, Including That of the Negative Regulator of Inflammation, MCPIP1* , 2013, The Journal of Biological Chemistry.

[19]  Y. E. Chen,et al.  MCPIP1 negatively regulates toll-like receptor 4 signaling and protects mice from LPS-induced septic shock. , 2013, Cellular signalling.

[20]  Xinyang Song,et al.  The activation and regulation of IL-17 receptor mediated signaling. , 2013, Cytokine.

[21]  Y. E. Chen,et al.  Targeted Disruption of MCPIP1/Zc3h12a Results in Fatal Inflammatory Disease , 2013, Immunology and cell biology.

[22]  N. Chai,et al.  Monoclonal anti-interleukin-6 receptor antibody attenuates donor-specific antibody responses in a mouse model of allosensitization. , 2013, Transplant immunology.

[23]  Shyr‐Yi Lin,et al.  MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation , 2013, Nucleic acids research.

[24]  D. Patel,et al.  Effect of IL-17A blockade with secukinumab in autoimmune diseases , 2012, Annals of the rheumatic diseases.

[25]  Wei Zhang,et al.  MCPIP1 Down-Regulates IL-2 Expression through an ARE-Independent Pathway , 2012, PloS one.

[26]  Z. Rao,et al.  MCP-1-induced protein-1, an immune regulator , 2012, Protein & Cell.

[27]  L. Skalniak,et al.  Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) is a novel multifunctional modulator of inflammatory reactions. , 2012, Biochimica et biophysica acta.

[28]  C. Dong,et al.  Negative regulation of IL-17-mediated signaling and inflammation by ubiquitin-specific protease 25 , 2012, Nature Immunology.

[29]  J. Zepp,et al.  Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17–Mediated Pathology and Signaling Processes , 2012, The Journal of Immunology.

[30]  J. Harley,et al.  The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α , 2012, Nature Medicine.

[31]  V. Poli,et al.  IL-6, IL-17 and STAT3: a holy trinity in auto-immunity? , 2012, Frontiers in bioscience.

[32]  Jian Liang,et al.  Participation of MCP-induced protein 1 in lipopolysaccharide preconditioning-induced ischemic stroke tolerance by regulating the expression of proinflammatory cytokines , 2011, Journal of Neuroinflammation.

[33]  Hiroshi I. Suzuki,et al.  MCPIP1 ribonuclease antagonizes dicer and terminates microRNA biogenesis through precursor microRNA degradation. , 2011, Molecular cell.

[34]  M. Chance,et al.  The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation , 2011, Nature Immunology.

[35]  T. Hamilton,et al.  Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF) , 2011, Nature Immunology.

[36]  D. Sturdevant,et al.  IL-17-induced NF-kappaB activation via CIKS/Act1: physiologic significance and signaling mechanisms. , 2011, The Journal of biological chemistry.

[37]  Jing Wang,et al.  MCP-induced protein 1 deubiquitinates TRAF proteins and negatively regulates JNK and NF-κB signaling , 2010, The Journal of experimental medicine.

[38]  Yufang Shi,et al.  Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling , 2010, The Journal of experimental medicine.

[39]  Shyamasree Datta,et al.  Diversity in post-transcriptional control of neutrophil chemoattractant cytokine gene expression. , 2010, Cytokine.

[40]  C. Tato,et al.  Innate IL-17-producing cells: the sentinels of the immune system , 2010, Nature Reviews Immunology.

[41]  W. Ouyang,et al.  IL-17RC Is Required for Immune Signaling via an Extended SEF/IL-17R Signaling Domain in the Cytoplasmic Tail , 2010, The Journal of Immunology.

[42]  S. Akira,et al.  Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. , 2010, Immunity.

[43]  J. Cowland,et al.  Induction of Neutrophil Gelatinase-associated Lipocalin Expression by Co-stimulation with Interleukin-17 and Tumor Necrosis Factor-α Is Controlled by IκB-ζ but neither by C/EBP-β nor C/EBP-δ* , 2010, The Journal of Biological Chemistry.

[44]  S. Gaffen,et al.  Interleukin‐17 and its target genes: mechanisms of interleukin‐17 function in disease , 2010, Immunology.

[45]  Shyamasree Datta,et al.  IL-17 Regulates CXCL1 mRNA Stability via an AUUUA/Tristetraprolin-Independent Sequence , 2009, The Journal of Immunology.

[46]  Zhijian J. Chen,et al.  Act1, a U-box E3 Ubiquitin Ligase for IL-17 Signaling , 2009, Science Signaling.

[47]  Haruki Nakamura,et al.  Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay , 2009, Nature.

[48]  B. Doble,et al.  IL-17 Receptor Signaling Inhibits C/EBPβ by Sequential Phosphorylation of the Regulatory 2 Domain , 2009, Science Signaling.

[49]  S. Gaffen,et al.  Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis , 2009, The Journal of experimental medicine.

[50]  David Baltimore,et al.  Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20. , 2008, Genes & development.

[51]  Zihua Hu,et al.  Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway. , 2008, The Journal of biological chemistry.

[52]  C. Quilici,et al.  Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: Critical role of neutrophils in defense against Candida albicans , 2008, Growth factors.

[53]  A. Maitra,et al.  Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression , 2007, Proceedings of the National Academy of Sciences.

[54]  Zihua Hu,et al.  Identification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes* , 2006, Journal of Biological Chemistry.

[55]  J. Berzofsky,et al.  Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function , 2005, The Journal of experimental medicine.

[56]  P. Schwarzenberger,et al.  Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. , 2004, The Journal of infectious diseases.

[57]  A. Ishisaki,et al.  Interleukin (IL)‐17 enhances tumor necrosis factor‐α‐stimulated IL‐6 synthesis via p38 mitogen‐activated protein kinase in osteoblasts , 2004, Journal of cellular biochemistry.

[58]  Sarah L. Gaffen,et al.  Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members* , 2004, Journal of Biological Chemistry.

[59]  W. Hahn,et al.  Human Keratinocytes That Express hTERT and Also Bypass a p16INK4a-Enforced Mechanism That Limits Life Span Become Immortal yet Retain Normal Growth and Differentiation Characteristics , 2000, Molecular and Cellular Biology.

[60]  B. Hilliard,et al.  IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. , 1998, Journal of immunology.

[61]  嶋田 光恵.  IL-6 secretion by human pancreatic periacinar myofibroblasts in response to inflammatory mediators , 2002 .

[62]  O. Eickelberg,et al.  Transforming growth factor-beta1 induces interleukin-6 expression via activating protein-1 consisting of JunD homodimers in primary human lung fibroblasts. , 1999, The Journal of biological chemistry.